Report: Gibbons received shipments of steroids and human growth hormone Print
Written by Admin   
Sunday, 09 September 2007 18:01
MLB Headline News

 NEW YORK (AP) -Baltimore Orioles outfielder Jay Gibbons received performance-enhancing steroids and human growth hormone after both substances were banned by baseball, SI.com reported Sunday.
Gibbons is the latest athlete to be linked to the Florida pharmacy under investigation for illegally distributing prescription medications.
Major League Baseball asked Friday to meet with St. Louis' Rick Ankiel and Toronto's Troy Glaus after two reports said they received performance-enhancing drugs from Signature Pharmacy several years ago.
Between October 2003 and July 2005, Gibbons got six shipments of Genotropin (a brand name for synthetic human growth hormone), two shipments of testosterone and two shipments of human chorionic gonadotropin (HCG), SI.com said, citing a source in Florida with knowledge of a Signature Pharmacy client list.
SI.com said its information dealt only with receipt of the drugs, not use.
Gibbons didn't immediately return a message left on his cell phone by The Associated Press. Messages left with his agent, Sam Levinson, also weren't immediately returned. Orioles spokesman Bill Stetka declined to comment.
Major League Baseball banned testosterone in 2003, the same year the sport began testing for steroids. HGH was barred in January 2005, but Gibbons allegedly received a shipment that July. HCG is not on the list of banned substances, SI.com reported.
Prescriptions that were written in Gibbons' name were sent to a Gilbert, Ariz., address that traces to the Baltimore outfielder, SI.com said.
The substances were obtained through South Beach Rejuvenation Center/Modern Therapy, a Miami Beach clinic, and sent through Signature, SI.com said.
The 30-year-old Gibbons underwent season-ending shoulder surgery last month to repair a torn labrum. The procedure ended his worst year in the majors - he batted .230 with only six homers and 28 RBIs in 84 games.
He broke into the majors in 2001 with the Orioles after being selected from the Toronto Blue Jays in the winter meeting draft. His best season was in 2003, when he batted .277 with 23 homers and 100 RBIs in 160 games.
But Gibbons has been plagued by injuries ever since. He played in 97 games in 2004, 139 in 2005 and last year he had two stints on the disabled list and played in only 90 games.
The Los Angeles Times reported last October that Gibbons was one of the players a federal agent said was implicated in drug use by former major league pitcher Jason Grimsley.
 

MLB Team Pages

Top MLB Public Bets

View All: NFL |  NBA |  NCAAF |  NCAAB |  MLB |  NHL

MLB Futures

MLB TEAM WORLD SERIES ODDS CURRENT
LOS ANGELES DODGERS 15/2
WASHINGTON NATIONALS 8/1
DETROIT TIGERS 10/1
LOS ANGELES ANGELS 12/1
ST LOUIS CARDINALS 12/1
SAN FRANCISCO GIANTS 12/1
CHICAGO CUBS 18/1
KANSAS CITY ROYALS 18/1
SEATTLE MARINERS 18/1
OAKLAND ATHLETICS 20/1
View All

Privacy Policy | Terms of Service | Contact Us | Advertising | 888-99-SPREAD

THIS IS NOT A GAMBLING SITE – If you think you have a gambling problem click here.

Disclaimer: This site is for informational and entertainment purposes only. Individual users are responsible for the laws regarding accessing gambling information from their jurisdictions. Many countries around the world prohibit gambling, please check the laws in your location. Any use of this information that may violate any federal, state, local or international law is strictly prohibited.

Copyright: The information contained on TheSpread.com website is protected by international copyright and may not be reproduced, or redistributed in any way without expressed written consent.

About: TheSpread.com is the largest sports betting news site in the United States. We provide point spread news, odds, statistics and information to over 199 countries around the world each year. Our coverage includes all North American College and Professional Sports as well as entertainment, political and proposition wagering news.

©1999-2013 TheSpread.com